Effect of growth hormone on bone: Bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone

Studies were performed to determine whether serum total alkaline phosphatase (SAP), an index of bone formation; body weight; total body bone mineral density (BMD), measured by dual‐energy X‐ray absorptiometry; and tibial trabecular bone volume (TBV), measured by histomorphometry, are reduced in 2‐week‐old female sexually immature Lewis dwarf (dw/dw) rats (DW‐CT, n = 9) with isolated growth hormone (GH) deficiency and, if so, whether recombinant human GH (rhGH), 200 μg/day subcutaneously for 4 weeks (DW‐GH, n = 7), restores them. Studies were also performed to determine if 30% dietary restriction in 2‐week‐old female Lewis rats (LW‐DR, n = 11) alters SAP, body weight, total BMD, or TBV compared with pair‐fed controls (LW‐CT, n = 7) given an ad libitum diet. Mean SAP (91 ± 5 versus 109 ± 5 U/l), body weight (102 ± 11 versus 140 ± 10 g), total BMD (88.5 ± 03 versus 101.4 ± 2.0 mg/cm2), and TBV (19.0 ± 1.0 versus 27.0 ± 1.4%) were significantly lower in DW‐CT than in LW‐CT animals, p < 0.05. In DW‐GH, rhGH significantly increased mean SAP (130 ± 7 U/l), body weight (133 ± 10 g), total BMD (92.7 ± 13), and TBV (24.0 ± 1.9) compared with DW‐CT animals. Compared with LW‐CT rats, mean body weight and TBV were not different, but mean SAP was significantly higher (p < 0.01) and mean total BMD was significantly lower (p < 0.003) in DW‐GH rats. In LW‐DR compared with LW‐CT animals, dietary restriction significantly reduced mean body weight (p < 0.05) but did not alter mean SAP, total BMD, or TBV. Thus, body weight, SAP, total BMD, and TBV were lower in DW‐CT than in LW‐CT rats. In the dose administered, SAP is markedly increased and reductions in body weight, total BMD, and TBV are completely or partially restored by treatment with rhGH in young female rats caused by isolated GH deficiency. Dietary restriction in young female rats with intact secretion of GH prevents weight gain but does not alter SAP, total BMD, or TBV compared with animals fed ad libitum.

[1]  M. Orth,et al.  Cortical bone growth and maturational changes in dwarf rats induced by recombinant human growth hormone. , 1996, The American journal of physiology.

[2]  D. Schoenfeld,et al.  Accuracy, precision, and utility of spine and whole‐skeleton mineral measurements by dxa in rats , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  H. Rosen,et al.  Parenteral pamidronate prevents thyroid hormone‐induced bone loss in rats , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  R. Kimble,et al.  Dual‐energy x‐ray absorptiometry of the rat: Accuracy, precision, and measurement of bone loss , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  J J Anderson,et al.  Effects of weight and body mass index on bone mineral density in men and women: The framingham study , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  P. Tapanainen,et al.  Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity. , 1993, The Journal of endocrinology.

[7]  S. Adami,et al.  Bone mineral density in children and adolescent females treated with high doses of L-thyroxine. , 1993, Hormone research.

[8]  R. Rizzoli,et al.  Sequential and precise in vivo measurement of bone mineral density in rats using dual‐energy x‐ray absorptiometry , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  A. Klibanski,et al.  Osteopenia in men with a history of delayed puberty. , 1992, The New England journal of medicine.

[10]  S. Mohan,et al.  Growth hormone stimulates cortical bone formation in immature hypophysectomized rats. , 1992, Endocrine research.

[11]  W. Goodman,et al.  Changes in vertebral bone density in black girls and white girls during childhood and puberty. , 1991, The New England journal of medicine.

[12]  L. Tatò,et al.  Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. , 1991, The Journal of pediatrics.

[13]  S. Mohan,et al.  Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. Scheven,et al.  Longitudinal bone growth in vitro: effects of insulin-like growth factor I and growth hormone. , 1991, Acta endocrinologica.

[15]  T. Martin,et al.  Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. , 1991, Endocrinology.

[16]  G. Howard,et al.  In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. , 1991, Bone.

[17]  D. Rudman,et al.  Effects of human growth hormone in men over 60 years old. , 1990, The New England journal of medicine.

[18]  J. C. Netelenbos,et al.  Growth hormone (replacement) therapy in adults: bone and calcium metabolism. , 1990, Hormone research.

[19]  A. Rogol,et al.  Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. , 1989, The Journal of clinical endocrinology and metabolism.

[20]  B. Bloch,et al.  Growth hormone-deficient dwarfism in the rat: a new mutation. , 1988, The Journal of endocrinology.

[21]  E. Froesch,et al.  Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. , 1988, Biochemical and biophysical research communications.

[22]  J. Jansson,et al.  Sexual dimorphism in the control of growth hormone secretion. , 1985, Endocrine reviews.

[23]  A. Schulz,et al.  Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF I in bone organ culture. , 1984, Acta endocrinologica.

[24]  L. Kuhns,et al.  Hand radiographic measurements in growth hormone deficiency before and after treatment. , 1977, AJR. American journal of roentgenology.

[25]  J. Aloia,et al.  Effects of growth hormone in osteoporosis. , 1976, The Journal of clinical endocrinology and metabolism.